These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30702538)

  • 1. Exploring Emergency Department Provider Experiences With and Perceptions of Weight-Based Versus Individualized Vaso-Occlusive Treatment Protocols in Sickle Cell Disease.
    Knight LMJ; Onsomu EO; Bosworth HB; Crawford RD; DeMartino T; Glassberg J; Paice JA; Miller CN; Richardson L; Tanabe P
    Adv Emerg Nurs J; 2019; 41(1):86-97. PubMed ID: 30702538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency department.
    Siewny L; King A; Melvin CL; Carpenter CR; Hankins JS; Colla JS; Preiss L; Luo L; Cox L; Treadwell M; Davila N; Masese RV; McCuskee S; Gollan SS; Tanabe P
    Blood Adv; 2024 Oct; 8(20):5330-5338. PubMed ID: 38815230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
    Tanabe P; Silva S; Bosworth HB; Crawford R; Paice JA; Richardson LD; Miller CN; Glassberg J
    Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial design of comparing patient-specific versus weight-based protocols to treat vaso-occlusive episodes in sickle cell disease (COMPARE-VOE).
    Ibemere SO; Dubbs SB; Barnhart HX; Brown JL; Freiermuth CE; Kavanagh P; Paice JA; Strouse JJ; Wilkerson RG; Tanabe P;
    Contemp Clin Trials; 2021 Feb; 101():106252. PubMed ID: 33348066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
    Kavanagh PL; Sprinz PG; Wolfgang TL; Killius K; Champigny M; Sobota A; Dorfman D; Barry K; Miner R; Moses JM
    Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: The emergency department providers' perspective.
    Masese RV; Bulgin D; Douglas C; Shah N; Tanabe P
    PLoS One; 2019; 14(5):e0216414. PubMed ID: 31063506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency Department Provider Survey Regarding Acute Sickle Cell Pain Management.
    Martin OY; Thompson SM; Carroll AE; Jacob SA
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):375-380. PubMed ID: 32569034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease.
    Harris EM; Vilk E; Heeney MM; Solodiuk J; Greco C; Archer NM
    Pediatr Blood Cancer; 2021 Jul; 68(7):e28989. PubMed ID: 33788404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to pain relief: A randomized controlled trial in the emergency department during vaso-occlusive episodes in sickle cell disease.
    Tanabe P; Bosworth HB; Crawford RD; Glassberg J; Miller CN; Paice JA; Silva S
    Eur J Haematol; 2023 May; 110(5):518-526. PubMed ID: 36602417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effect of patient-specific versus weight-based protocols to treat vaso-occlusive episodes in the emergency department.
    Tanabe P; Ibemere S; Pierce AE; Freiermuth CE; Bosworth HB; Yang H; Osunkwo I; Paxton JH; Strouse JJ; Miller J; Paice JA; Veeramreddy P; Kavanagh PL; Wilkerson RG; Hughes R; Barnhart HX
    Acad Emerg Med; 2023 Dec; 30(12):1210-1222. PubMed ID: 37731093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study.
    Luo L; King AA; Carroll Y; Baumann AA; Brambilla D; Carpenter CR; Colla J; Gibson RW; Gollan S; Hall G; Klesges L; Kutlar A; Lyon M; Melvin CL; Norell S; Mueller M; Potter MB; Richesson R; Richardson LD; Ryan G; Siewny L; Treadwell M; Zun L; Armstrong-Brown J; Cox L; Tanabe P
    JMIR Res Protoc; 2021 Apr; 10(4):e24818. PubMed ID: 33861209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "The project did not come to us with a solution": Perspectives of research teams on implementing a study about electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease.
    Baumann AA; Hankins JS; Hsu LL; Gibson RW; Richardson LD; Treadwell M; Glassberg JA; Bourne S; Luo L; Masese RV; Demartino T; Nocek J; Taaffe E; Gollan S; Ruiz OO; Nwosu C; Qashou N; James AS; Tanabe P; King AA
    BMC Health Serv Res; 2023 Nov; 23(1):1245. PubMed ID: 37953236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do children with sickle cell disease receive disparate care for pain in the emergency department?
    Zempsky WT; Loiselle KA; McKay K; Lee BH; Hagstrom JN; Schechter NL
    J Emerg Med; 2010 Nov; 39(5):691-5. PubMed ID: 19703740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
    Kato-Lin YC; Krishnamurti L; Padman R; Seltman HJ
    Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management.
    Tanabe P; Hafner JW; Martinovich Z; Artz N
    Acad Emerg Med; 2012 Apr; 19(4):430-8. PubMed ID: 22506947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to reducing admissions for children with sickle cell disease in pain crisis through individualization and standardization in the emergency department.
    Schefft MR; Swaffar C; Newlin J; Noda C; Sisler I
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27274. PubMed ID: 29856534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
    Bulgin D; Bonnabeau E; Alexander A; Frederick E; Rains G; Shah N; Young M; Tanabe P
    J Emerg Nurs; 2021 Jan; 47(1):40-49.e1. PubMed ID: 32826064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.
    Rees CA; Brousseau DC; Cohen DM; Villella A; Dampier C; Brown K; Campbell A; Chumpitazi CE; Airewele G; Chang T; Denton C; Ellison A; Thompson A; Ahmad F; Bakshi N; Coleman KD; Leibovich S; Leake D; Hatabah D; Wilkinson H; Robinson M; Casper TC; Vichinsky E; Morris CR;
    Trials; 2023 Aug; 24(1):538. PubMed ID: 37587492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaso-occlusive episodes in older children with sickle cell disease: emergency department management and pain assessment.
    Frei-Jones MJ; Baxter AL; Rogers ZR; Buchanan GR
    J Pediatr; 2008 Feb; 152(2):281-5. PubMed ID: 18206703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Survey-Based Needs Assessment of Barriers to Optimal Sickle Cell Disease Care in the Emergency Department.
    Linton EA; Goodin DA; Hankins JS; Kanter J; Preiss L; Simon J; Souffront K; Tanabe P; Gibson R; Hsu LL; King A; Richardsona LD; Glassberg JA;
    Ann Emerg Med; 2020 Sep; 76(3S):S64-S72. PubMed ID: 32928465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.